|
HY-50901-10mg
|
MedChemexpress LLC
|
ONO-AE3-208 [CAS 402473-54-5]
|
|
Cancer-programmed cell death
|
|
|
HY-50901-5mg
|
MedChemexpress LLC
|
ONO-AE3-208 [CAS 402473-54-5]
|
|
Cancer-programmed cell death
|
|
|
HY-50901-50mg
|
MedChemexpress LLC
|
ONO-AE3-208 [CAS 402473-54-5]
|
|
Cancer-programmed cell death
|
|
|
HY-50901-1mL
|
MedChemexpress LLC
|
ONO-AE3-208 [CAS 402473-54-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-16988A-10mg
|
MedChemexpress LLC
|
SR9011 (hydrochloride) [CAS 2070014-94-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16988A-100mg
|
MedChemexpress LLC
|
SR9011 (hydrochloride) [CAS 2070014-94-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16988A-2mg
|
MedChemexpress LLC
|
SR9011 (hydrochloride) [CAS 2070014-94-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16988A-5mg
|
MedChemexpress LLC
|
SR9011 (hydrochloride) [CAS 2070014-94-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16988A-50mg
|
MedChemexpress LLC
|
SR9011 (hydrochloride) [CAS 2070014-94-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16988A-1mL
|
MedChemexpress LLC
|
SR9011 (hydrochloride) [CAS 2070014-94-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-16988-10mg
|
MedChemexpress LLC
|
SR9011 [CAS 1379686-29-9]
|
|
Cancer-programmed cell death
|
|
|
HY-16988-100mg
|
MedChemexpress LLC
|
SR9011 [CAS 1379686-29-9]
|
|
Cancer-programmed cell death
|
|
|
HY-16988-2mg
|
MedChemexpress LLC
|
SR9011 [CAS 1379686-29-9]
|
|
Cancer-programmed cell death
|
|
|
HY-16988-5mg
|
MedChemexpress LLC
|
SR9011 [CAS 1379686-29-9]
|
|
Cancer-programmed cell death
|
|
|
HY-16988-50mg
|
MedChemexpress LLC
|
SR9011 [CAS 1379686-29-9]
|
|
Cancer-programmed cell death
|
|
|
HY-16988-1mL
|
MedChemexpress LLC
|
SR9011 [CAS 1379686-29-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-10426-10mg
|
MedChemexpress LLC
|
XCT790 [CAS 725247-18-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10426-5mg
|
MedChemexpress LLC
|
XCT790 [CAS 725247-18-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10426-50mg
|
MedChemexpress LLC
|
XCT790 [CAS 725247-18-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10426-1mL
|
MedChemexpress LLC
|
XCT790 [CAS 725247-18-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
C427630-100mg
|
Toronto Research Chemicals
|
4-Chlorobenzoic anhydride [CAS 790-41-0]
|
|
|
|
|
SR300555
|
OriGene Technologies
|
CAD Human siRNA Oligo Duplex (Locus ID 790)
|
|
|
|
|
GTX28407
|
GeneTex International Corporation
|
CAD, Rabbit Polyclonal Antibody
|
Human, Mouse, Rat
|
ICC/IF, WB
|
|
|
150-10532
|
RayBiotech, Inc.
|
IgG iFluor 790 conjugate, Donkey Polyclonal Antibody
|
Mouse
|
|
|
|
HY-D1052-10mg
|
MedChemexpress LLC
|
Cy7-YNE
|
|
|
|
